167 related articles for article (PubMed ID: 38050280)
61. Treating breast implant-associated anaplastic large cell lymphoma.
McKernan C
JAAPA; 2021 Apr; 34(4):47-51. PubMed ID: 33735141
[TBL] [Abstract][Full Text] [Related]
62. Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines.
Lillemoe HA; Miranda RN; Nastoupil LJ; Clemens MW; Hunt KK
Ann Surg Oncol; 2022 Sep; 29(9):5722-5729. PubMed ID: 35597841
[TBL] [Abstract][Full Text] [Related]
63. Management of Symptomatic Patients with Textured Implants.
Asaad M; Offodile AC; Santanelli Di Pompeo F; Bevers TB; Stelly S; Carew LA; Barnea Y; Miranda RN; Butler CE; Clemens MW
Plast Reconstr Surg; 2021 May; 147(5S):58S-68S. PubMed ID: 33890882
[TBL] [Abstract][Full Text] [Related]
64. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
Nelson JA; McCarthy C; Dabic S; Polanco T; Chilov M; Mehrara BJ; Disa JJ
Plast Reconstr Surg; 2021 May; 147(5S):7S-13S. PubMed ID: 33890875
[TBL] [Abstract][Full Text] [Related]
65. 26 Years of Textured Implants and BIA-ALCL: Continued Vigilance and Counseling Are Warranted.
Dabic S; McCarthy CM; Matros E; Disa JJ; Mehrara BJ; Nelson JA
Plast Reconstr Surg; 2021 Sep; 148(3):517e-518e. PubMed ID: 34346912
[No Abstract] [Full Text] [Related]
66. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
[TBL] [Abstract][Full Text] [Related]
67. Is Banning Texturized Implants to Prevent Breast Implant-Associated Anaplastic Large Cell Lymphoma a Rational Decision? A Meta-Analysis and Cost-Effectiveness Study.
Danilla SV; Jara RP; Miranda F; Bencina F; Aguirre M; Troncoso E; Erazo CA; Andrades PR; Sepulveda SL; Albornoz CR
Aesthet Surg J; 2020 Jun; 40(7):721-731. PubMed ID: 31761953
[TBL] [Abstract][Full Text] [Related]
68. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Immediate or Delayed Implant Replacement?
Shine JJ; Boghossian E; Beauchemin G; Papanastasiou VW; Borsuk DE
Aesthetic Plast Surg; 2018 Dec; 42(6):1492-1498. PubMed ID: 30094550
[TBL] [Abstract][Full Text] [Related]
69. Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL.
Longo B; Di Napoli A; Curigliano G; Veronesi P; Pileri S; Martelli M; De Vita R; Felici N; Cirillo P; Bernardi C; D'orsi G; Giacalone M; Storti G; Cervelli V
Breast; 2022 Dec; 66():332-341. PubMed ID: 36502569
[TBL] [Abstract][Full Text] [Related]
70. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in Brazil: What Are We Missing?
Groth AK; Clemens MW; Graf R; Sebastião AP; Azambuja AP; Louveira MH; Urban LABD; Batista BN
Plast Reconstr Surg; 2022 Nov; 150(5):970e-978e. PubMed ID: 35994334
[TBL] [Abstract][Full Text] [Related]
71. Is Breast Implant-Associated Anaplastic Large Cell Lymphoma Better Classified as a Lymphoproliferative Disorder and How Surgeons Reduce Risk?
Lukavsky RJ; Couto RA; Adams WP
Clin Plast Surg; 2021 Jan; 48(1):71-77. PubMed ID: 33220906
[TBL] [Abstract][Full Text] [Related]
72. A Spectrum of Disease: Breast Implant-Associated Anaplastic Large Cell Lymphoma, Atypicals, and Other Implant Associations.
Fracol ME; Rodriguez MM; Clemens MW
Clin Plast Surg; 2023 Apr; 50(2):249-257. PubMed ID: 36813403
[TBL] [Abstract][Full Text] [Related]
73. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) - The first case in Taiwan.
Lai CS; Wu CY; Chen IC; Tsai YC
Asian J Surg; 2021 Jun; 44(6):869-870. PubMed ID: 33934969
[No Abstract] [Full Text] [Related]
74. Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Perry L; Radzevich J; Kelter D; Gott M; Slotman G; Kulkarni N; Gundlapalli V
Am Surg; 2022 Aug; 88(8):2065-2067. PubMed ID: 32931319
[No Abstract] [Full Text] [Related]
75. Breast implant-associated anaplastic large-cell lymphoma: A series of two case reports diagnosed by cytopathology.
Hrones M; Harigopal M; Xu M; Abi-Raad R
Diagn Cytopathol; 2023 Jan; 51(1):E25-E27. PubMed ID: 36066320
[TBL] [Abstract][Full Text] [Related]
76. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
[TBL] [Abstract][Full Text] [Related]
77. Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Blombery P; Thompson ER; Prince HM
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. PubMed ID: 30817557
[TBL] [Abstract][Full Text] [Related]
78. Smooth Versus Textured Tissue Expander Breast Reconstruction: Complications and Efficacy.
McLaughlin C; Hughes AJ; Parham CS; Fritsche M; Potochny JD; Kunselman A; Ravnic DJ
Ann Plast Surg; 2022 May; 88(3 Suppl 3):S288-S292. PubMed ID: 35513333
[TBL] [Abstract][Full Text] [Related]
79. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
[TBL] [Abstract][Full Text] [Related]
80. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Report of 2 Cases and Review of the Literature.
Hart AM; Lechowicz MJ; Peters KK; Holden J; Carlson GW
Aesthet Surg J; 2014 Aug; 34(6):884-94. PubMed ID: 24938778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
